VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $339,523 | -50.7% | 12,617 | -34.5% | 0.08% | -67.8% |
Q1 2023 | $688,355 | -20.6% | 19,252 | -36.3% | 0.26% | -48.6% |
Q4 2022 | $866,535 | +187.9% | 30,235 | +174.9% | 0.50% | +154.4% |
Q2 2022 | $301,000 | -98.3% | 11,000 | -98.0% | 0.20% | -96.8% |
Q1 2021 | $17,875,000 | +178.4% | 550,000 | +128.8% | 6.06% | +146.2% |
Q3 2019 | $6,421,000 | +3226.9% | 240,400 | -38.9% | 2.46% | +3576.1% |
Q2 2017 | $193,000 | -56.5% | 393,200 | +0.1% | 0.07% | -54.1% |
Q1 2017 | $444,000 | – | 393,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |